Home/Filings/4/0001078782-18-001449
4//SEC Filing

Faulkes Martin Charles 4

Accession 0001078782-18-001449

CIK 0000093314other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 5:07 PM ET

Size

16.9 KB

Accession

0001078782-18-001449

Insider Transaction Report

Form 4
Period: 2018-12-20
Transactions
  • Award

    Option (Right to Buy)

    2018-12-20+30,00030,000 total
    Exercise: $2.50From: 2015-02-18Exp: 2020-08-18Common Stock (30,000 underlying)
  • Award

    Option (Right to Buy)

    2018-12-20+40,00040,000 total
    Exercise: $4.00From: 2016-01-23Exp: 2021-07-23Common Stock (40,000 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2018-12-2030,0000 total
    Exercise: $3.00From: 2016-02-18Exp: 2020-02-18Common Stock (30,000 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2018-12-2030,0000 total
    Exercise: $2.50From: 2015-02-18Exp: 2019-02-18Common Stock (30,000 underlying)
  • Award

    Option (Right to Buy)

    2018-12-20+30,00030,000 total
    Exercise: $3.00From: 2016-02-18Exp: 2020-08-18Common Stock (30,000 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2018-12-2040,0000 total
    Exercise: $4.00From: 2016-01-23Exp: 2020-01-23Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020.
  • [F2]The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2021.

Issuer

VOLITIONRX LTD

CIK 0000093314

Entity typeother

Related Parties

1
  • filerCIK 0001577872

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:07 PM ET
Size
16.9 KB